Pharma & Biotech

Viking Therapeutics, a clinical-stage biopharmaceutical company, captured significant investor interest this week following its presentation at the Piper Sandler Healthcare...

After an extraordinary surge that saw its value multiply more than fourfold this year, Cogent Biosciences is experiencing a significant...

A significant deadline has arrived for one of Germany's most closely watched biotech narratives. The offer period for BioNTech's exchange...

The year 2025 is shaping up to be a formidable challenge for Novo Nordisk, with its share price having plummeted...

Investors in Redcare Pharmacy are witnessing a relentless sell-off, with the stock's value eroding rapidly. The critical question now is...

Bionxt Solutions has announced a major strategic expansion, positioning itself to access a multi-billion dollar segment within the oncology and...

Shares of Intellia Therapeutics are experiencing significant downward pressure, with the stock price declining 3.80% to $8.10 as investor sentiment...

Investors in Ocugen are facing a critical test of resolve. The biotech firm's shares have been under persistent downward pressure,...

Pharmaceutical titan Eli Lilly has launched an aggressive offensive in the lucrative weight-loss drug sector, initiating a price war that...

The shares of Viking Therapeutics have delivered a remarkable 34% gain over the past three months, signaling a powerful resurgence....